loading
Precedente Chiudi:
$0.2311
Aprire:
$0.2299
Volume 24 ore:
3.17M
Relative Volume:
0.18
Capitalizzazione di mercato:
$2.76M
Reddito:
-
Utile/perdita netta:
$-11.53M
Rapporto P/E:
-0.0481
EPS:
-4.82
Flusso di cassa netto:
$-11.12M
1 W Prestazione:
+9.69%
1M Prestazione:
+9.23%
6M Prestazione:
-64.69%
1 anno Prestazione:
-86.11%
Intervallo 1D:
Value
$0.222
$0.2352
Intervallo di 1 settimana:
Value
$0.209
$0.2497
Portata 52W:
Value
$0.15
$1.6677

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name
Nome
Processa Pharmaceuticals Inc
Name
Telefono
443-776-3133
Name
Indirizzo
7380 COCA COLA DRIVE, HANOVER
Name
Dipendente
13
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
PCSA's Discussions on Twitter

Confronta PCSA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PCSA
Processa Pharmaceuticals Inc
0.232 9.16M 0 -11.53M -11.12M -4.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
366.54 98.88B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.00 58.84B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
438.93 56.12B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
661.83 41.20B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
288.18 35.49B 3.81B -644.79M -669.77M -6.24

Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-04-25 Iniziato H.C. Wainwright Buy

Processa Pharmaceuticals Inc Borsa (PCSA) Ultime notizie

pulisher
12:24 PM

How to use Fibonacci retracement on Processa Pharmaceuticals Inc.Free Chart Breakout Buy Signal Detection - Newser

12:24 PM
pulisher
Aug 09, 2025

Why Processa Pharmaceuticals Inc. is moving todayPrice Movement and Market Sentiment Analysis - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Processa Pharmaceuticals Reports Increased Losses Amid Strategic Developments - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

Biotech-Fintech Synergy in Capital Strategy: How Processa Pharmaceuticals' Crypto Treasury Initiative Could Reshape Shareholder Value - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Processa Pharmaceuticals, Inc. SEC 10-Q Report - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Processa Pharmaceuticals explores cryptocurrency treasury strategy By Investing.com - Investing.com Nigeria

Aug 07, 2025
pulisher
Aug 07, 2025

Processa Pharmaceuticals explores cryptocurrency treasury strategy - Investing.com India

Aug 07, 2025
pulisher
Aug 07, 2025

Processa Pharmaceuticals secures strategic investment and evaluates corporate crypto treasury strategies - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Processa Pharmaceuticals Secures Strategic Investment and Explores Cryptocurrency Treasury Strategies for Long-Term Growth - Quiver Quantitative

Aug 07, 2025
pulisher
Aug 07, 2025

Processa Pharmaceuticals Secures Strategic Investment, Evaluates Crypto Treasury Strategies - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies - GlobeNewswire

Aug 07, 2025
pulisher
Aug 07, 2025

PLBY regains Nasdaq compliance with new independent director appointment | PCSA SEC FilingForm 8-K - Stock Titan

Aug 07, 2025
pulisher
Aug 07, 2025

Biotech Pioneer Processa Pharmaceuticals Embraces Crypto: Strategic Investment Meets Blockchain Innovation - Stock Titan

Aug 07, 2025
pulisher
Aug 06, 2025

Real time breakdown of Processa Pharmaceuticals Inc. stock performanceLow Risk High Confidence Watchlist Builder - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Chart based analysis of Processa Pharmaceuticals Inc. trendsChart Driven Entry Timing for Swing Trades - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Is Processa Pharmaceuticals Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Pattern Detection for Entry Confirmation - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Elliott Wave Theory Predicts Pullback in Processa Pharmaceuticals Inc.Consistent Profit Pattern Recognition Tools Shared - beatles.ru

Aug 05, 2025
pulisher
Aug 05, 2025

Can momentum traders help lift Processa Pharmaceuticals Inc.Free Entry Alert With Low Drawdown Strategy - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Volatility clustering patterns for Processa Pharmaceuticals Inc.Chart Signal and Short-Term Forecast Tracker - Newser

Aug 05, 2025
pulisher
Aug 03, 2025

Using data tools to time your Processa Pharmaceuticals Inc. exitEntry Zone Watchlist With Momentum Focus - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Processa Pharmaceuticals Inc. stock price move sharplyEntry Signal Generator with Risk Metrics - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

Is Processa Pharmaceuticals Inc. a good long term investmentExpert guidance for superior capital growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Processa Pharmaceuticals Inc. stock perform well during market downturnsDiscover breakthrough investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about Processa Pharmaceuticals Inc.Invest confidently with daily market forecasts - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Processa Pharmaceuticals Inc. stock in 2025Invest smarter with expert stock recommendations - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Processa Pharmaceuticals Inc. stock expected to show significant growthExplosive earnings growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Processa Pharmaceuticals Inc. generate profit in a changing economyDiscover stocks with explosive upside potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Processa Pharmaceuticals Inc. compare to its industry peersMarket-crushing profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Processa Pharmaceuticals Inc. stockTrack stocks with high upside potential easily - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Processa Pharmaceuticals Inc. company’s growth strategyAccelerated financial growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What catalysts could drive Processa Pharmaceuticals Inc. stock higher in 2025Invest in stocks with long-term growth potential - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What drives Processa Pharmaceuticals Inc. stock priceBuild wealth steadily with proven investment techniques - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Multi factor analysis applied to Processa Pharmaceuticals Inc.Momentum Detection with Entry Optimization - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

How Processa Pharmaceuticals Inc. stock performs during market volatilityTechnical Reversal Setup with Risk Limits - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

What are analysts’ price targets for Processa Pharmaceuticals Inc. in the next 12 monthsReal Time Guidance For 2025 - Jammu Links News

Aug 01, 2025
pulisher
Jul 31, 2025

Will Processa Pharmaceuticals Inc. outperform the marketPattern Recognition Based Market Move Prediction - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

How many analysts rate Processa Pharmaceuticals Inc. as a “Buy”Breakout Stocks Insights To Watch Now - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Top Risks to Consider Before Buying Processa Pharmaceuticals Inc. StockFree Oversold Recovery Opportunity Stocks - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Institutional scanner results for Processa Pharmaceuticals Inc.Intraday Movement Recap and Chart Summary - Newser

Jul 31, 2025

Processa Pharmaceuticals Inc Azioni (PCSA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Processa Pharmaceuticals Inc Azioni (PCSA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Ng George K
Chief Executive Officer
Jan 27 '25
Buy
0.80
87,200
69,542
87,200
Young David
Pres. Research & Development
Jan 27 '25
Buy
0.80
124,500
99,289
205,405
Lin Patrick
Chief Business - Strategy Off
Jan 27 '25
Buy
0.80
43,500
34,691
43,500
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
Capitalizzazione:     |  Volume (24 ore):